← Back to All Filings

Hologic CFO Awarded RSUs, Sells Shares for Tax Obligations

Low SignificanceNovember 12, 2025 at 4:36:59 PM EST

HOLOGIC INC

$HOLX4CIK: 0000859737

Subscribe to track HOLX

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Hologic CFO Awarded RSUs, Sells Shares for Tax Obligations

Company: HOLOGIC INC (HOLX) Form: 4 | Filed: 2025-11-12 Significance: Low

Insider: Oberton Karleen Marie Title: Chief Financial Officer | Relationship: Officer

Transaction (Primary): • Type: Grant (RSU Award) • Shares: 43,741 • Price: $0.00 • Value: $0 (Notional value ~$3.26M) • Owned After: 152,068

Key Insight: The CFO received a routine RSU grant as part of her compensation. Subsequent sales were automatic dispositions to cover tax liabilities from vesting units and are not discretionary trades.

Market Context: These transactions are standard executive compensation events and have a negligible impact on Hologic's $16.54 billion market capitalization.

Comprehensive Analysis

SEC Filing Analysis: HOLOGIC INC (HOLX)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: Hologic's CFO, Karleen Marie Oberton, received a routine grant of 43,741 Restricted Stock Units (RSUs) and subsequently disposed of a total of 10,876 shares in non-discretionary transactions to cover tax obligations.
  • Market Impact: Negligible. These are standard, non-discretionary compensation events that do not signal a change in insider sentiment.

Company Information

FieldValue
CompanyHOLOGIC INC
Ticker SymbolHOLX
CIK0000859737
IndustryX-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS

Insider Information

FieldValue
NameOberton Karleen Marie
CIK0001314036
Title/PositionChief Financial Officer
RelationshipOfficer

Transaction Details

This filing reports three transactions: one RSU grant and two tax-related dispositions. The primary event is the RSU grant.

FieldValue
Form Type4
Transaction Date2025-11-10
Transaction CodeA (Grant)
Security TypeCommon Stock (as RSUs)
Shares Involved43,741
Price Per Share$0.00
Total Value$0
Shares Owned After152,068
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

The analysis focuses on the RSU grant, which is the most significant component of the filing.

MetricValue
Transaction Value$0 (Notional value of grant: ~$3.26M based on recent trading prices)
% of Market Cap~0.02% (based on notional value)
Shares Transacted43,741
% of Shares Outstanding0.0197%
Post-Transaction Ownership152,068 shares (0.068% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The grant's notional value is insignificant relative to Hologic's $16.54 billion market capitalization.
  • Ownership Concentration: The CFO's total holdings remain a very small fraction of the company's total shares outstanding.
  • Dilution Impact: The 43,741 new RSUs represent a minimal potential dilution of approximately 0.02% for existing shareholders, which is a standard part of executive compensation programs.
  • Transaction Significance: The transactions are low significance. The grant is a routine compensation event, and the sales (Code 'F') are automatic withholdings to satisfy tax liabilities, not discretionary market sales.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The filing details standard executive compensation activities. The dispositions are non-discretionary tax-related events, which do not reflect the insider's sentiment about the company's future prospects.

Volume & Sentiment

  • Expected Volume Impact: None. The transactions are not open-market trades that would affect trading volume.
  • Sentiment Indicator: Neutral. This filing is informational regarding executive compensation and does not provide a bullish or bearish signal.

Additional Context

Transaction Notes

  • The filing documents an award of RSUs (Code 'A') and two separate dispositions (Code 'F') to cover tax obligations from vesting equity. As noted in footnote F1, these are not discretionary sales but are required withholdings.
Topics:#Hologic#HOLX#SECFiling#Form4#InsiderTrading#CFO#ExecutiveComp#RSU#StockMarket

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.